NOX4 and acute myeloid leukemia: To investigate the involvement of NOX4 inhibition in the observed antiproliferative effects on AML cells, we tested Setanaxib on the human AML cell lines MV4-11 and MOLM13, either expressing NOX4 or after genetic inactivation of NOX4 by CRISPR/Cas9 technology.